Solenic Medical launches AMF breakthrough device for the treatment of prosthetic joint infections.
The new technology will be considered as a most effective treatment in providing timely access to patients with life-threatening or irreversibly debilitating conditions.
This device destructs the approach of biofilm on metallic implants thereby giving advantage for completely non-invasive treatment of PJI.The device is the firstproduct designed for the treatment of most metallic medical implants including knees, hips, elbows, trauma devices and more.
Prosthetic Joint Infections (PJI), is recognised to be one of the most serious complications in arthroplasty field.Currently, treatment of PJI involves a two-stage revision requiring two additional surgeries and weeks of antibiotic treatment.Though it can be effective, the two-stage revision procedure is very expensive and resulted in having high failure rates, posing significant morbidity to high-risk patients thus having negative impact on quality of life.
Prosthetic joint infections are generally seen in increasing aging population. Hence, the new technology developed will provide significant solutions for prosthetic joint infections thereby reducing the risk of growing aging population suffering with prosthetic joint infections.